California Legal Brief

The Rule of Chapman v. Avon Products is that expert testimony about asbestos testing methodology is admissible when the witness demonstrates sufficient knowledge, skill, experience, or training to interpret test results relevant to their field of expertise, under circumstances where the expert relies on established scientific principles even if using older or modified techniques.

Appeal from judgment after jury trial in Superior Court, Los Angeles County.

Defendant Appellant was Avon Products, Inc. — the cosmetics manufacturer whose talcum powder products allegedly contained asbestos and caused plaintiff's mesothelioma.

Plaintiff Respondent was Gary Chapman, individually and as personal representative — the widower and successor-in-interest to his deceased wife Rita-Ann Chapman, who used Avon talc products from 1954-1978 and 1995-2010 before developing mesothelioma.

The suit sounded in products liability, negligence, fraudulent misrepresentation, and fraudulent concealment. The central issues were whether Avon's talc products contained asbestos and whether such exposure caused Mrs. Chapman's mesothelioma.

The key substantive facts leading to the suit were Rita-Ann Chapman's decades-long use of Avon talcum powder products beginning at age 8, her subsequent diagnosis with mesothelioma, and Avon's internal documents from the early 1970s acknowledging asbestos contamination in their talc sources, with some showing tremolite asbestos levels as high as 25 percent.

The procedural result leading to the Appeal: The trial court admitted Dr. Longo's expert testimony about chrysotile asbestos detection using modified older testing methods, excluded Avon's corporate witness Lisa Gallo for lack of proper disclosure and personal knowledge, and admitted Dr. Haber's medical expert testimony interpreting asbestos testing methodologies and corporate documents. The jury awarded $40,831,453 in compensatory damages and $10.3 million in punitive damages, finding Avon 90 percent at fault.

The key question(s) on Appeal: 1. Whether the trial court abused its discretion in admitting Dr. Longo's testimony about chrysotile detection without requiring proof of general acceptance under Kelly/Frye standards 2. Whether the trial court erred in excluding Avon's corporate witness Lisa Gallo based on disclosure and personal knowledge requirements 3. Whether Dr. Haber was qualified to testify about asbestos testing methods and interpret corporate documents outside his medical expertise 4. Whether substantial evidence supported the jury's findings on causation and liability

The Appellate Court held that the trial court properly exercised its gatekeeping function under Sargon by determining Dr. Longo's testing methodology was scientifically reliable and logically supported, properly excluded the corporate witness who lacked personal knowledge of relevant facts, and correctly allowed Dr. Haber's testimony within his qualified expertise as a pulmonologist treating asbestos-related diseases. Avon waived its sufficiency challenge by failing to summarize all material evidence favorable and unfavorable to its position.

The case is inapplicable when the expert witness lacks sufficient knowledge, training, or experience in the relevant field, when testing methodology is based on speculation rather than established scientific principles, or when corporate witnesses can demonstrate proper disclosure and personal knowledge of the facts to which they would testify.

The case leaves open the precise boundaries of when medical experts may interpret technical testing data outside their primary field, the extent to which older scientific methodologies require Kelly/Frye analysis when modified, and what specific disclosure requirements satisfy personal knowledge standards for corporate witnesses.